Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance
Miriam Marqués(Spanish National Cancer Research Centre), Francisco X. Real(Universitat Pompeu Fabra)
Cited by 4
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
|The Lancet|2005|631
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
|European Urology|2013|289
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis
|Nature Genetics|2006|250